Comparison of clinical outcomes of several risk stratification tools in newly diagnosed AML patients: A real ‐world evidence in our current therapeutic era

ConclusionsUsing Akaike ’s information criteria (AIC) to compare all five classifiers, ELN 2022 is the best classifier into younger and older patients and for prognosis.

Source: Cancer Medicine - March 20, 2024 Category: Cancer & Oncology Authors: Alexandre Iat, Michael Loschi, Sami Benachour, Anne Calleja, Edmond Chiche, Isabelle Sudaka, Dani èle Aquaronne, Corinne Ferrero, Laurène Fenwarth, Alice Marceau, Elise Fournier, Berengere Dadone‐Montaudie, Thomas Cluzeau Tags: RESEARCH ARTICLE Source Type: research